Company News
-
September 06, 2023
bioMérieux’s Future-Proof Portfolio of Diagnostic Solutions and Services Ensure End-to-End Compliance with Changing Cronobacter Regulations and Calls-To-Action
In recognition of National Food Safety Education Month, bioMérieux, a world leader in in vitro diagnostics, continues its long-standing collaboration with the food safety industry to provide a comprehensive suite of solutions and services for infant formula manufacturers and ingredient suppliers to minimize risk of Cronobacter spp, Salmonella and other microbiological hazards at every stage of the production process.
-
May 16, 2023
bioMérieux Triples Footprint in Philadelphia with 32,000 sq. ft. State-Of-The-Art Predictive Diagnostics Innovation Center
bioMérieux, a world leader in in vitro diagnostics, has announced the lease signing of a new, 32,000 sq. ft. state-of-the-art molecular innovation center at the Navy Yard in Philadelphia.
-
April 20, 2023
bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)
bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR. -
March 07, 2023
bioMérieux Introduces GENE-UP® PRO GENDER ID and GENE-UP® PRO HOP LATENT VIROID (HLVd) Solutions
bioMérieux, a world leader in in vitro diagnostics for 60 years, is pleased to announce the availability of GENE-UP® PRO GENDER ID and GENE-UP® PRO HOP LATENT VIROID (HLVd) quality control solutions.
-
February 21, 2023
bioMérieux launches a PCR kit for detection of the monkeypox virus
bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.
Follow us on Socials for more news!
